HOME >> MEDICINE >> NEWS
Studying the fate of drugs in wastewater

Researchers at the National Institute of Standards and Technology (NIST) have published an interesting study that sheds light on the fate of a familiar pharmaceutical as it enters the waste stream. In work initially described last year, NIST chemists investigated probable chemical reactions involving acetaminophen when the drug is subjected to typical wastewater processing. Acetaminophen is the most widely used pain reliever in the United States, and a study of 139 streams by the U.S. Geological Survey found that it was one of the most frequently detected man-made chemicals.

The scientists found that the drug readily reacts in chlorine disinfection to form at least 11 new products, at least two of which are known to be toxic. The results, according to lead author Mary Bedner, demonstrate that environmental scientists need to be concerned about downstream reaction products as well as the original waste materials. "The issue is what you should be looking for in the environment," she says. "When you are looking for the effects of pharmaceuticals in the environment, you need to ask what they're going to turn into."


'"/>

Contact: Michael Baum
michael.baum@nist.gov
301-975-2763
National Institute of Standards and Technology (NIST)
23-Dec-2005


Page: 1

Related medicine news :

1. Studying brain activity could aid diagnosis of social phobia
2. UIC researchers to develop new drugs to fight bioterrorism
3. Statin drugs may delay progressive artery damage in children
4. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
5. Experts call for urgent research into anti-epileptic drugs given to children
6. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
7. Antipsychotic drugs increase risk of death in older people with dementia
8. Antipsychotic drugs increase risk of death in older people with dementia
9. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
10. Panel offers guidelines on skin reactions to new class of cancer drugs
11. Blood-thinning drugs need closer monitoring

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Studying the fate drugs wastewater

(Date:5/26/2015)... Beginning this fall, Boston University will ... Master of Social Work (MSW) program . Already available ... River Campus, the online option will be offered starting ... option is open to applicants holding an undergraduate social ... Education. Students entering the program will be granted 22 ...
(Date:5/26/2015)... Dearborn Ear, Nose & Throat in Dearborn, MI ... and improved website to better showcase their Detroit area ... Nose & Throat’s new website utilizes an innovative and ... seamlessly on any desktop computer, tablet or mobile device. ... Nose & Throat website include an innovative design ...
(Date:5/25/2015)... 2015 The report “Liver Failure ... on the therapeutic development for Liver Failure. The ... and MOAs to produce first-in-class and best-in-class products. ... Liver Failure with 22 market data tables and ... at http://www.rnrmarketresearch.com/liver-failure-pipeline-review-h1-2015-market-report.html . , Companies discussed ...
(Date:5/25/2015)... (PRWEB) May 26, 2015 Author Vincent N. ... of people today are overweight, and many of them aren’t ... He also knows that most people don’t realize the dangers ... hazards and man-made toxins that exist. There is ... realize exactly how serious tobacco is.” , In “ A ...
(Date:5/25/2015)... City, NY (PRWEB) May 26, 2015 ... honors Laquanis Hooker as a 2015-2016 inductee into its ... recognized with this prestigious distinction for leadership in dentistry. ... professional women, boasting more than 700,000 members and over ... welcome Laquanis into this exceptional group of professional women,” ...
Breaking Medicine News(10 mins):Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 2Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 3Health News:Dearborn Ear, Nose & Throat Launches ‘Responsive Design’ Website 2Health News:Liver Failure Pipeline Assessment and Key Players Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Liver Failure Pipeline Assessment and Key Players Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Liver Failure Pipeline Assessment and Key Players Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:New Book Reveals ‘A Doctor’s Prescription for Longevity and Survival’ 2Health News:New Book Reveals ‘A Doctor’s Prescription for Longevity and Survival’ 3Health News:National Association of Professional Women Inducts Dr. Laquinas Hooked, D.D.S. of General Dentist, Into its VIP Professional Woman of the Year Circle 2
(Date:5/22/2015)... -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage drug development ... announced that J.J. Finkelstein , chief executive officer ... at two upcoming investor conferences. Mr. ... Annual Microcap Conference on Thursday May 28, 2015 in ... am EDT.  A webcast will be available at the ...
(Date:5/22/2015)... -- The Mesothelioma Victims Center is incredibly passionate about ... best possible compensation, and they are also extremely focused ... caused by exposure to asbestos or their family ... options such as a recent possible medical breakthrough. For ... anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
(Date:5/22/2015)... May 22, 2015 Research and Markets ... of the "Latest Regulations on Pharmaceutical International ... their offering. This is first time ... guidance on international multi-center clinical trials of drugs ... begun to be implemented on March 1, 2015. ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
Cached News: